Abstract
The phakomatoses, or neurocutaneous syndromes, are a group of disorders affecting structures of ectodermal origin
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Vezina G, Barkovich A (2012) The phakomatoses. In: Barkovich A, Raybaud C (eds) Pediatric neuroimaging. Lippincott, Williams & Wilkins, Philadelphia, pp 569–636
Korf BR (2004) The phakomatoses. Neuroimaging Clin N Am 14:139–148
National Institutes of Health Consensus Development Conference (1988) Neurofibromatosis. Conference statement. Arch Neurol 45:575–578
Tidyman WE, Rauen KA (2009) The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation. Curr Opin Genet Dev 19:230–236
Pong WW, Gutmann DH (2011) The ecology of brain tumors: lessons learned from neurofibromatosis-1. Oncogene 30:1135–1146
Rodriguez D, Young Poussaint T (2004) Neuroimaging findings in neurofibromatosis type 1 and 2. Neuroimaging Clin N Am 14:149–170
Shamji MF, Benoit BG (2007) Syndromic and sporadic pediatric optic pathway gliomas: review of clinical and histopathological differences and treatment implications. Neurosurg Focus 23:E3
Huttner AJ, Kieran MW, Yao X et al (2010) Clinicopathologic study of glioblastoma in children with neurofibromatosis type 1. Pediatr Blood Cancer 54:890–896
Ullrich NJ, Raja AI, Irons MB et al (2007) Brainstem lesions in neurofibromatosis type 1. Neurosurgery 61:762–766
Sevick RJ, Barkovich AJ, Edwards MS et al (1992) Evolution of white matter lesions in neurofibromatosis type 1: MR findings. AJR Am J Roentgen 159:171–175
DiPaolo DP, Zimmerman RA, Rorke LB et al (1995) Neurofibromatosis type 1: pathologic substrate of high-signal-intensity foci in the brain. Radiology 195:721–724
Zamboni SL, Loenneker T, Boltshauser E et al (2007) Contribution of diffusion tensor MR imaging in detecting cerebral microstructural changes in adults with neurofibromatosis type 1. AJNR Am J Neuroradiol 28:773–776
Parry DM, Eldridge R, Kaiser-Kupfer MI et al (1994) Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity. Am J Med Genet 52:450–461
Kotecha RS, Junckerstorff RC, Lee S et al (2011) Pediatric meningioma: current approaches and future direction. J Neurooncol 104:1–10
Dancey J (2010) mTOR signaling and drug development in cancer. Nat Rev Clin Oncol 7:209–219
Braffman B, Naidich TP (1994) The phakomatoses: Part I. Neurofibromatosis and tuberous sclerosis. Neuroimaging Clin N Am 4:299–324
Krishnan ML, Commowick O, Jeste SS et al (2010) Diffusion features of white matter in tuberous sclerosis with tractography. Pediatr Neurol 42:101–106
Simao G, Raybaud C, Chuang S et al (2010) Diffusion tensor imaging of commissural and projection white matter in tuberous sclerosis complex and correlation with tuber load. AJNR Am J Neuroradiol 31:1273–1277
Griffiths PD, Coley SC, Romanowski CA et al (2003) Contrast-enhanced fluid-attenuated inversion recovery imaging for leptomeningeal disease in children. AJNR Am J Neuroradiol 24:719–723
Wu J, Tarabishy B, Hu J et al (2011) Cortical calcification in Sturge-Weber Syndrome on MRI-SWI: relation to brain perfusion status and seizure severity. J Magn Reson Imaging 34:791–798
Hu J, Yu Y, Juhasz C et al (2008) MR susceptibility weighted imaging (SWI) complements conventional contrast enhanced T1 weighted MRI in characterizing brain abnormalities of Sturge-Weber Syndrome. J Magn Reson Imaging 28:300–307
Vickers MM, Heng DY (2010) Prognostic and predictive biomarkers in renal cell carcinoma. Target Oncol 5:85–94
Frieden IJ, Reese V, Cohen D (1996) PHACE syndrome. The association of posterior fossa brain malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects, and eye abnormalities. Arch Dermatol 132:307–311
Metry D, Heyer G, Hess C et al (2009) Consensus Statement on Diagnostic Criteria for PHACE Syndrome. Pediatrics 124:1447–1456
Hess CP, Fullerton HJ, Metry DW et al (2010) Cervical and intracranial arterial anomalies in 70 patients with PHACE syndrome. AJNR Am J Neuroradiol 31:1980–1986
Burrows PE, Robertson RL, Mulliken JB et al (1998) Cerebral vasculopathy and neurologic sequelae in infants with cervicofacial hemangioma: report of eight patients. Radiology 207:601–607
Poindexter G, Metry DW, Barkovich AJ et al (2007) PHACE syndrome with intracerebral hemangiomas, heterotopia, and endocrine dysfunction. Pediatr Neurol 36:402–406
Gorlin RJ, Sedano HO (1971) The multiple nevoid basal cell carcinoma syndrome revisited. Birth Defects Orig Artic Ser 7:140–148
Gorlin RJ (1995) Nevoid basal cell carcinoma syndrome. Dermatol Clin 13:113–125
Bree AF, Shah MR (2011) Consensus statement from the first international colloquium on basal cell nevus syndrome (BCNS). Am J Med Genet 155:2091–2097
Garre ML, Cama A, Bagnasco F et al (2009) Medulloblastoma variants: age-dependent occurrence and relation to Gorlin syndrome — a new clinical perspective. Clin Cancer Res 15:2463–2471
Kadonaga JN, Barkovich AJ, Edwards MS et al (1992) Neurocutaneous melanosis in association with the Dandy-Walker complex. Pediatr Dermatol 9:37–43
Kim KH, Chung SB, Kong DS et al (2011) Neurocutaneous melanosis associated with Dandy-Walker complex and an intracranial cavernous angioma. Childs Nerv Syst 28:309–3140
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Italia
About this paper
Cite this paper
Poussaint, T.Y. (2012). Imaging of the Phakomatoses in Children. In: Hodler, J., von Schulthess, G.K., Zollikofer, C.L. (eds) Diseases of the Brain, Head & Neck, Spine 2012–2015. Springer, Milano. https://doi.org/10.1007/978-88-470-2628-5_40
Download citation
DOI: https://doi.org/10.1007/978-88-470-2628-5_40
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-2627-8
Online ISBN: 978-88-470-2628-5
eBook Packages: MedicineMedicine (R0)